The Impact of Federal Life Science Funding on University R&D

联邦生命科学资助对 R 大学的影响

基本信息

批准号：
1064215
负责人：
Krishna Kumar
金额：
$ 10.07万
依托单位：
Rand Corporation
依托单位国家：
美国
项目类别：
Standard Grant
财政年份：
2011
资助国家：
美国
起止时间：
2011-05-15 至 2013-04-30
项目状态：
已结题

来源：
https://www.nsf.gov/awardsearch/showAward?AWD_ID=1064215&HistoricalAwards=false
关键词：
Impact Federal Life Science Funding

项目摘要

Funding for academic research, especially in the life sciences, has risen rapidly over the last decade, totaling $18 billion in 2008. The American Recovery and Reinvestment Act of 2009 (ARRA) provided an additional $8.2 billion in federal resources to fund life science research at universities and other academic centers. This research examines the impact of the funding by tracing the path of federal funding through the research pipeline. The particular effects considered include additional funding from non-federal sources, the creation of applied knowledge, and the commercialization of ideas.The intellectual merit of the project is the development of empirical methods and conduct of analysis that uses ARRA 2009 as a "natural experiment" to analyze the effects of an increase in federal R&D funding on non-federal funding at universities. It also uses econometric techniques to examine the impact of federal funding for R&D in the life sciences on patents granted to universities. Finally, it uses data on firm alliances and conducts preliminary analysis to understand the effects of federal funding on alliance formation, productivity, and commercialization of research.Broader Impacts: The research involves the construction of a novel dataset that combines federal funding data and university-firm alliance outcomes, setting the stage for more detailed empirical assessment in the future by the research community. The research sheds light on how a dollar of federal research expenditure translates into knowledge and medical products as it traverses the research pathway. In sum, the research provides more information whereby policymakers in science and technology can assess the benefits of taxpayer-funded life sciences research to society at large, and provide guidance on the strengths to capitalize on and weaknesses to address.

在过去的十年中，学术研究的资金，尤其是在生命科学中，在2008年总计180亿美元。2009年的《美国复苏与再投资法》（ARRA）为联邦资源提供了82亿美元的资金，以资助大学和其他学术中心的生命科学研究。这项研究通过追踪通过研究管道来追踪联邦资金的道路来研究资金的影响。考虑的特殊效果包括来自非联邦来源的额外资金，应用知识的创造以及思想的商业化。该项目的智力优点是开发经验方法和分析的行为，该分析将ARRA 2009用作“自然实验”来分析联邦R＆D资金对大学非考察资金的增加的影响。它还使用计量经济学技术来研究联邦资金对研发对赋予大学专利的影响的影响。最后，它使用有关公司联盟的数据并进行初步分析，以了解联邦资金对研究联盟形成，生产力和研究的影响。BROADER的影响：研究涉及构建新型数据集，该数据集结合了联邦资金数据和大学 - 实施联盟的成果，并通过研究界为阶段提供了详细的经验评估。该研究阐明了一美元的联邦研究支出如何在遍历研究途径时转化为知识和医疗产品。总而言之，这项研究提供了更多信息，从而使科学技术的决策者可以评估纳税人资助的生命科学研究对整个社会的好处，并提供有关资本化和解决弱点的优势的指导。